Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ANET vs GSK✓SelectedUSD · GSKANET vs GSK performance historyLatest closeAs of-11.59%11/20
Stock and ETF performance explorer

ANET vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,738.6%
GSK return
+97.4%
Excess return
+2,641.2%
Maximum drawdown
-52.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.6%-0.1%-11.5%-11.6%
7D-15.0%-5.3%-9.7%-14.1%
30D-9.1%-3.7%-5.4%-8.4%
3M-8.8%-7.3%-1.5%-7.5%
6M+19.3%-4.2%+23.6%+19.2%
YTD+27.9%+0.9%+27.1%+25.4%
1Y+40.2%+7.3%+32.9%+35.0%
3Y+211.4%+52.7%+158.6%+158.6%
5Y+419.9%+40.1%+379.8%+338.8%
All+2,738.6%+97.4%+2,641.2%+2,062.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling